Schedule 13G ownership disclosure
CYTEIR THERAPEUTICS INC
Security class unavailable · CUSIP: 23284P103
Event date: 2021-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-086866
- Form type
- SC 13G
- Filer
- Cyteir Therapeutics, Inc.
- CIK
- CIK 1662244
- Filed
- Jun 29, 2021
- Reporting period
- Jun 22, 2021
- Description
- Schedule 13G beneficial ownership